A detailed history of Eqis Capital Management, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 7,116 shares of NVS stock, worth $699,858. This represents 0.07% of its overall portfolio holdings.

Number of Shares
7,116
Previous 8,671 17.93%
Holding current value
$699,858
Previous $923,000 11.38%
% of portfolio
0.07%
Previous 0.08%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$106.13 - $120.89 $165,032 - $187,983
-1,555 Reduced 17.93%
7,116 $818,000
Q2 2024

Aug 13, 2024

SELL
$92.57 - $107.37 $2,962 - $3,435
-32 Reduced 0.37%
8,671 $923,000
Q1 2024

May 14, 2024

SELL
$95.27 - $108.47 $48,587 - $55,319
-510 Reduced 5.54%
8,703 $841,000
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $83,319 - $91,690
903 Added 10.87%
9,213 $930,000
Q3 2023

Nov 13, 2023

SELL
$94.73 - $105.13 $151,283 - $167,892
-1,597 Reduced 16.12%
8,310 $846,000
Q2 2023

Aug 14, 2023

SELL
$92.52 - $104.91 $121,478 - $137,746
-1,313 Reduced 11.7%
9,907 $999,000
Q1 2023

May 15, 2023

SELL
$80.03 - $92.81 $184,629 - $214,112
-2,307 Reduced 17.05%
11,220 $1.03 Million
Q4 2022

Feb 14, 2023

SELL
$75.55 - $92.52 $111,662 - $136,744
-1,478 Reduced 9.85%
13,527 $1.23 Million
Q3 2022

Oct 24, 2022

SELL
$74.61 - $87.26 $432,663 - $506,020
-5,799 Reduced 27.87%
15,005 $1.14 Million
Q2 2022

Aug 08, 2022

SELL
$80.52 - $93.75 $58,779 - $68,437
-730 Reduced 3.39%
20,804 $1.76 Million
Q1 2022

May 16, 2022

BUY
$80.11 - $90.62 $1.73 Million - $1.95 Million
21,534 New
21,534 $1.89 Million
Q2 2021

Aug 12, 2021

SELL
$85.24 - $94.15 $354,001 - $391,004
-4,153 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$83.5 - $98.47 $202,821 - $239,183
-2,429 Reduced 36.9%
4,153 $355,000
Q4 2020

Feb 11, 2021

SELL
$78.07 - $94.43 $83,378 - $100,851
-1,068 Reduced 13.96%
6,582 $622,000
Q3 2020

Nov 10, 2020

SELL
$82.14 - $91.0 $70,886 - $78,533
-863 Reduced 10.14%
7,650 $665,000
Q2 2020

Aug 10, 2020

SELL
$80.93 - $91.1 $39,736 - $44,730
-491 Reduced 5.45%
8,513 $743,000
Q1 2020

May 12, 2020

BUY
$70.67 - $99.01 $54,981 - $77,029
778 Added 9.46%
9,004 $863,000
Q4 2019

Jan 24, 2020

SELL
$84.35 - $95.37 $84,771 - $95,846
-1,005 Reduced 10.89%
8,226 $779,000
Q3 2019

Nov 05, 2019

SELL
$85.54 - $94.26 $60,818 - $67,018
-711 Reduced 7.15%
9,231 $802,000
Q2 2019

Jul 18, 2019

SELL
$75.4 - $92.8 $727,157 - $894,963
-9,644 Reduced 49.24%
9,942 $908,000
Q1 2019

Apr 18, 2019

BUY
$75.32 - $86.15 $96,484 - $110,358
1,281 Added 7.0%
19,586 $1.88 Million
Q4 2018

Jan 25, 2019

SELL
$73.66 - $82.02 $167,060 - $186,021
-2,268 Reduced 11.02%
18,305 $1.57 Million
Q3 2018

Oct 17, 2018

BUY
$66.94 - $77.43 $16,467 - $19,047
246 Added 1.21%
20,573 $1.7 Million
Q2 2018

Jul 27, 2018

BUY
$64.91 - $73.36 $102,363 - $115,688
1,577 Added 8.41%
20,327 $1.54 Million
Q1 2018

Apr 06, 2018

SELL
$70.39 - $84.15 $37,306 - $44,599
-530 Reduced 2.75%
18,750 $1.52 Million
Q4 2017

Jan 25, 2018

BUY
$72.33 - $77.64 $10,343 - $11,102
143 Added 0.75%
19,280 $1.62 Million
Q3 2017

Oct 03, 2017

BUY
$74.14 - $77.27 $1.42 Million - $1.48 Million
19,137
19,137 $1.64 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.